Agilent Technolgies, the Santa Clara, US-based scientific instrument manufacturer, has acquired instrument manufacturer and contract research organisation (CRO), Biocius Life Sciences, for an undisclosed amount.
Agilent and BioTrove have forged a non-exclusive mass spectrometry partnership designed to enhance the screening of candidate drug compounds in early stage development.
The American Society for Mass Spectrometry meeting (ASMS) was the
scene of a lot of activity from Agilent this week as the lab
instrument specialist unleashed new mass spectrometer products at
the show.
Agilent Technologies report a 20 per cent drop in its first quarter
profit as a healthy revenue growth is offset by restructuring,
higher stock-based compensation costs and other expenses.
Researchers at the Broad Institute of MIT and Harvard, USA, have
successfully employed a new technique developed by Agilent that
could potentially eliminate one of the biggest bottlenecks in the
genetic sequencing process.
LabTechnologist.com brings you a round up of recent product
releases, with new offering from Agilent, Applied Biosystems,
Grabner, Jeol USA and Velocity11.
Agilent has signed a definitive agreement to acquire automation
expert Velocity11 for an undisclosed amount to enable it to speed
up drug discovery and genomics research.
Applied Biosystems (ABI) has successfully protected more of its PCR
(polymerase chain reaction) patents with Agilent agreeing to
license its thermal cycler technology.
LabTechnologist.com brings you a round-up of industry news, with
developments at Affymetrix, Agilent, Bruker Daltonics, Ciphergen
(now Vermillion) and Emerson Process Management.
Agilent has licensed Kreatech's non-enzymatic labelling technology
to allow researchers to study preserved tumour samples that would
otherwise be too degraded to study on its microarray platform.
Agilent has launched a new tool that removes the 14 most abundant
proteins found in blood plasma and serum to speed up the discovery
and identification of low-abundance proteins and biomarkers.
LabTechnologist.com brings you a round-up of some of the latest
product news, with developments at Agilent, Bruker Daltonics,
Labcyte, Millipore, NoAb, PerkinElmer, Radleys and Sigma-Aldrich.
LabTechnologist.com presents its periodic round up of recent
industry news with new developments at Agilent, Beckman Coulter,
Carl Zeiss, DuPont, Luminex and PerkinElmer.
LabTechnologist.com presents its periodic round up of recent
industry news with new developments at Agilent, Ciphergen,
Illumina, Inverness, PerkinElmer and Thermo Fisher Scientific.
Agilent Technologies has signed an agreement with Groton Biosystems
to co-market measuring solutions for the pharmaceutical industry,
as the Process Analytical Technology (PAT) initiative gains
popularity among drug manufacturers...
The National Cancer Institute (NCI) has revealed the grant
recipients for its Cancer Genome Atlas pilot project, which will
see three institutions using microarray platforms from Agilent
Technologies.
Agilent Technologies has chosen Distek to be its number-one
provider for dissolution instrumentation service in North America
under its Lab Resource Management (LRM) programme.
Agilent has launched a new line of HPLC columns, which is set to
deliver industry-leading separation performance for analytical,
high-resolution and fast LC applications, including pharmaceutical,
QA/QC, environmental and food-safety...
Agilent introduces its next generation of assay kits for its 2100
Bioanalyser Lab-on-a-Chip platform that aims to replace
labour-intensive SDS-PAGE and capillary gel electrophoresis (CGE)
methods providing faster microfluidic analyses.
Agilent have dived in to grab a slice of the growing $1.3 bn mass
spectrometry market with the launch of a series of new liquid
chromatography-based mass spectrometry (LC/MS) systems that are
cheaper and faster.
Agilent has launched a Laboratory Resource Management (LRM) service
for life science and pharmaceutical laboratories that promises to
improve productivity, reduce service costs and simplfy
administration.
A hive of activity at Agilent Technologies has trnsformed the
company into a significant player in the competitive microarray
platform market with the expansion of its array-based genomics,
disease research and drug R&D applications.
Agilent Technologies has launched what it claims is the industry's
first fully automated, high-throughput 'lab-on-a-chip system' for
basic life science research and drug discovery. The Agilent 5100
Automated provides...
